Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Altocor SAVE program

Executive Summary

McKesson will administer Andrx' Select Altocor for Value & Effectiveness discount card plan for extended-release lovastatin. Under the program slated for June launch, Altocor users will pay approximately $18 less per month for the drug; a year's supply will cost up to $1,000 less than other branded statins. SAVE has no age or income restrictions and will encompass cash payers as well as patients with insurance. Andrx previously said the program would target cash-paying seniors ("The Pink Sheet" March 31, p. 25)...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS041637

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel